Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Fiegl

Showing results (21-30 of 115) with videos related to

Pageof 12
Sort By:
Journal of Clinical Medicine|April 8, 2020
The Prognostic Impact of Comorbidities in Patients with De-Novo Diffuse Large B-Cell Lymphoma Treated with R-CHOP Immunochemotherapy in Curative IntentFlorian Kocher, Michael Mian, Andreas Seeber, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2013
Putative stem cell markers in non-small-cell lung cancer: a clinicopathologic characterizationWillam Sterlacci, Spasenija Savic, Michael Fiegl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
Modeling the pharmacodynamics of highly schedule-dependent agents: exemplified by cytarabine-based regimens in acute myeloid leukemiaJan Braess, Michael Fiegl, Isolde Lorenz, et al.
Leukemia & Lymphoma|October 22, 2013
Rituximab: how evidence based medicine can change our clinical practiceMichael Mian, Stefan Gritsch, Ines Wasle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Transendothelial migration of myeloma cells is increased by tumor necrosis factor (TNF)-alpha via TNF receptor 2 and autocrine up-regulation of MCP-1Karin Jöhrer, Katrin Janke, Jens Krugmann, et al.
Cytometry. Part B, Clinical Cytometry|October 7, 2004
FISH cytogenetics and prognosis in breast and non-small cell lung cancersAnita Massoner, Florian Augustin, Hans-Christoph Duba, et al.
Cancer Research|July 3, 2008
The warburg effect in leukemia-stroma cocultures is mediated by mitochondrial uncoupling associated with uncoupling protein 2 activationIsmael Samudio, Michael Fiegl, Teresa McQueen, et al.
Virchows Archiv : an International Journal of Pathology|August 5, 2009
Clinical relevance of neuroendocrine differentiation in non-small cell lung cancer assessed by immunohistochemistry: a retrospective study on 405 surgically resected casesWilliam Sterlacci, Michael Fiegl, Wolfgang Hilbe, et al.
The Breast Journal|January 14, 2004
Blood dissemination of mammaglobin-specific RNA during core needle biopsy in patients with invasive breast carcinomaKurt Grünewald, Margot Haun, Michael Fiegl, et al.
Leukemia & Lymphoma|August 5, 2004
Burkitt's lymphoma of the stomach: a case report with molecular cytogenetic analysisJens Krugmann, Alexandar Tzankov, Michael Fiegl, et al.
Pageof 12

Showing results (21-30 of 115) with videos related to

Sort By:
Pageof 12
Journal of Clinical Medicine|April 8, 2020
The Prognostic Impact of Comorbidities in Patients with De-Novo Diffuse Large B-Cell Lymphoma Treated with R-CHOP Immunochemotherapy in Curative IntentFlorian Kocher, Michael Mian, Andreas Seeber, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2013
Putative stem cell markers in non-small-cell lung cancer: a clinicopathologic characterizationWillam Sterlacci, Spasenija Savic, Michael Fiegl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2005
Modeling the pharmacodynamics of highly schedule-dependent agents: exemplified by cytarabine-based regimens in acute myeloid leukemiaJan Braess, Michael Fiegl, Isolde Lorenz, et al.
Leukemia & Lymphoma|October 22, 2013
Rituximab: how evidence based medicine can change our clinical practiceMichael Mian, Stefan Gritsch, Ines Wasle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Transendothelial migration of myeloma cells is increased by tumor necrosis factor (TNF)-alpha via TNF receptor 2 and autocrine up-regulation of MCP-1Karin Jöhrer, Katrin Janke, Jens Krugmann, et al.
Cytometry. Part B, Clinical Cytometry|October 7, 2004
FISH cytogenetics and prognosis in breast and non-small cell lung cancersAnita Massoner, Florian Augustin, Hans-Christoph Duba, et al.
Cancer Research|July 3, 2008
The warburg effect in leukemia-stroma cocultures is mediated by mitochondrial uncoupling associated with uncoupling protein 2 activationIsmael Samudio, Michael Fiegl, Teresa McQueen, et al.
Virchows Archiv : an International Journal of Pathology|August 5, 2009
Clinical relevance of neuroendocrine differentiation in non-small cell lung cancer assessed by immunohistochemistry: a retrospective study on 405 surgically resected casesWilliam Sterlacci, Michael Fiegl, Wolfgang Hilbe, et al.
The Breast Journal|January 14, 2004
Blood dissemination of mammaglobin-specific RNA during core needle biopsy in patients with invasive breast carcinomaKurt Grünewald, Margot Haun, Michael Fiegl, et al.
Leukemia & Lymphoma|August 5, 2004
Burkitt's lymphoma of the stomach: a case report with molecular cytogenetic analysisJens Krugmann, Alexandar Tzankov, Michael Fiegl, et al.
Pageof 12